These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II? Florisson DS; Conte SM; De Bono JA; Newcomb AE Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825 [TBL] [Abstract][Full Text] [Related]
13. Initial conservative management strategy of HeartWare left ventricular assist device thrombosis with intravenous heparin or bivalirudin. Bouzas-Cruz N; Gonzalez-Fernandez O; Ferrera-Durán C; Woods A; Robinson-Smith N; Tovey S; Jungschleger J; Booth K; Shah A; Parry G; MacGowan GA; Schueler S Int J Artif Organs; 2020 Jul; 43(7):444-451. PubMed ID: 31885316 [TBL] [Abstract][Full Text] [Related]
19. Retrograde washout of prepump LVAD thrombosis in a patient on HeartWare™ support. Elbayomi M; Weyand M; Heim C; Steger K; Tandler R J Card Surg; 2022 Oct; 37(10):3440-3442. PubMed ID: 35894824 [TBL] [Abstract][Full Text] [Related]
20. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy. Pedde D; Soltani S; Stein J; Tsyganenko D; Müller M; Schönrath F; Falk V; Potapov EV Eur J Cardiothorac Surg; 2020 Feb; 57(2):325-330. PubMed ID: 31317177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]